Sinossi
Live Attenuated Viral Vaccines.- Inactivated Viral Vaccines.- Recombinant Virus Like Particle Protein Vaccines.- Analysis of influenza vaccines.- Live-attenuated and inactivated whole-cell bacterial vaccines.- Analytical control strategy of bacterial subunit vaccines.- Bacterial Polysaccharide Vaccines: Analytical Perspectives.- Glycoconjugate vaccines.- Vaccines in research and development: new production platforms and new biomolecular entities for new needs.- Role of Analytics In Viral Safety.- Deep Sequencing Applications for Vaccine Development and Safety.- Quality-by-design: As related to analytical concepts, control and qualification.- Vaccine Potency Assays.- Establishing a Shelf-life and Setting Lot-release Specifications.- Vaccine Reference Standards.- Lot Release of Vaccines by Regulatory Authorities and Harmonization of Testing Requirements.- Dendritic cell targeting vaccines.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
